Phase II multiclinic study of elantrine in parkinsonism.
D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003984:Dibenzazepines / Q000627:therapeutic use*; D004123:Dimethylamines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D009127:Muscle Rigidity / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*; D014202:Tremor / Q000188:drug therapy; D014282:Trihexyphenidyl / Q000627:therapeutic use
D000978:Antiparkinson Agents; D003984:Dibenzazepines; D004123:Dimethylamines; D014282:Trihexyphenidyl